These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 1828134

  • 1. Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts.
    Van der Auwera P, Aoun M, Meunier F.
    Antimicrob Agents Chemother; 1991 Mar; 35(3):451-7. PubMed ID: 1828134
    [Abstract] [Full Text] [Related]

  • 2. Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon.
    Gilbert DN, Wood CA, Kimbrough RC.
    Antimicrob Agents Chemother; 1991 Jan; 35(1):79-87. PubMed ID: 1826594
    [Abstract] [Full Text] [Related]

  • 3. Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.
    Van Laethem Y, Hermans P, De Wit S, Goosens H, Clumeck N.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():81-7. PubMed ID: 2965135
    [Abstract] [Full Text] [Related]

  • 4. Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin.
    Greenberg RN.
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2392-7. PubMed ID: 2150908
    [Abstract] [Full Text] [Related]

  • 5. Teicoplanin administration in patients experiencing reactions to vancomycin.
    Smith SR, Cheesbrough JS, Makris M, Davies JM.
    J Antimicrob Chemother; 1989 May; 23(5):810-2. PubMed ID: 2527221
    [No Abstract] [Full Text] [Related]

  • 6. Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria.
    Glupczynski Y, Lagast H, Van der Auwera P, Thys JP, Crokaert F, Yourassowsky E, Meunier-Carpentier F, Klastersky J, Kains JP, Serruys-Schoutens E.
    Antimicrob Agents Chemother; 1986 Jan; 29(1):52-7. PubMed ID: 2942100
    [Abstract] [Full Text] [Related]

  • 7. Teicoplanin in the treatment of infection caused by gram-positive organisms.
    Williams AH, Grüneberg RN, Webster A, Ridgway GL.
    J Hosp Infect; 1986 Mar; 7 Suppl A():101-3. PubMed ID: 2871091
    [Abstract] [Full Text] [Related]

  • 8. Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters.
    Smith SR, Cheesbrough J, Spearing R, Davies JM.
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1193-7. PubMed ID: 2529814
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of novel glycopeptides versus vancomycin for the treatment of gram-positive bacterial infections including methicillin resistant Staphylococcus aureus: A systematic review and meta-analysis.
    Jame W, Basgut B, Abdi A.
    PLoS One; 2021 Aug; 16(11):e0260539. PubMed ID: 34843561
    [Abstract] [Full Text] [Related]

  • 10. Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.
    Menichetti F, Martino P, Bucaneve G, Gentile G, D'Antonio D, Liso V, Ricci P, Nosari AM, Buelli M, Carotenuto M.
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2041-6. PubMed ID: 7811016
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
    Sidi V, Roilides E, Bibashi E, Gompakis N, Tsakiri A, Koliouskas D.
    J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982
    [Abstract] [Full Text] [Related]

  • 13. Teicoplanin in the treatment of skin and soft tissue infections: results of a multicentre study.
    Lang E, Földes M, Marghescu S.
    Infection; 1991 Aug; 19(3):190-4. PubMed ID: 1832418
    [Abstract] [Full Text] [Related]

  • 14. A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria.
    Lewis P, Garaud JJ, Parenti F.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():61-7. PubMed ID: 2965133
    [Abstract] [Full Text] [Related]

  • 15. Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: an open study.
    Pauluzzi S, Del Favero A, Menichetti F, Baratta E, Moretti VM, Di Filippo P, Pasticci MB, Guerciolini R, Patoia L, Frongillo RF.
    J Antimicrob Chemother; 1987 Sep; 20(3):431-8. PubMed ID: 2960643
    [Abstract] [Full Text] [Related]

  • 16. Bactericidal activity and killing rate of serum in volunteers receiving vancomycin or teicoplanin with and without amikacin given intravenously.
    Van der Auwera P, Klastersky J.
    J Antimicrob Chemother; 1987 May; 19(5):623-35. PubMed ID: 2956228
    [Abstract] [Full Text] [Related]

  • 17. [The comparative costs of vancomycin treatment versus teicoplanin in osteoarticular infection caused by methicillin-resistant staphylococci].
    Pham Dang C, Gouin F, Touchais S, Richard C, Potel G.
    Pathol Biol (Paris); 2001 Sep; 49(7):587-96. PubMed ID: 11642024
    [Abstract] [Full Text] [Related]

  • 18. Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis.
    Svetitsky S, Leibovici L, Paul M.
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4069-79. PubMed ID: 19596875
    [Abstract] [Full Text] [Related]

  • 19. Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.
    Chow AW, Jewesson PJ, Kureishi A, Phillips GL.
    Eur J Haematol Suppl; 1993 Oct; 54():18-24. PubMed ID: 8365461
    [Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections.
    Bibler MR, Frame PT, Hagler DN, Bode RB, Staneck JL, Thamlikitkul V, Harris JE, Haregewoin A, Bullock WE.
    Antimicrob Agents Chemother; 1987 Feb; 31(2):207-12. PubMed ID: 2952062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.